Commonwealth Bank of Australia reports: what you need to know

Commonwealth Bank of Australia (ASX:CBA) has kept its interim dividend unchanged for the first time since 2009.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia (ASX: CBA) has achieved a better-than-expected cash net profit after tax (NPAT) result for the six-months ended 31 December 2015, while it also elected to keep its interim dividend unchanged.

Statutory NPAT rose 2% compared to the prior corresponding period (pcp) to $4.62 billion, but the cash NPAT, which the banks prefer to focus on, rose 4% to $4.8 billion. That was better than the estimate of slightly higher than $4.7 billion cash NPAT, according to The Sydney Morning Herald.

Although the bank's loan impairment expense rose 3%, its loan loss ratio remained steady at 17 basis points. Its net interest margin, which reflects the measure of profitability on its loans, also remained flat at 2.06%.

While cash NPAT rose 4%, cash earnings per share (EPS) only rose 1% to $2.84. EPS grew at a slower pace than cash NPAT itself because of the bank's $5.1 billion capital raising late last year which came as a result of the Australian Prudential Regulation Authority's (APRA) tightened capital measures.

Ensuring the banks hold more capital against the loans they write, these regulations were designed to protect the banks (together with shareholders and taxpayers) in the event of another major economic downturn.

However, the capital raising also had an impact on the group's Return on Equity (ROE) – a key performance measure for the banks – which fell 140 basis points to 17.2%. The bank also kept its interim dividend unchanged at $1.98, representing a payout ratio of 70.8% of cash NPAT.

Indeed, there had been much speculation regarding the dividend leading into today's announcement – particularly following speculation that both Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd. (ASX: NAB) may need to cut their own dividends.

Some estimates suggested Commonwealth Bank's dividend could fall to $1.88 per share, while others said it could rise to $2.02. Instead, it chose to leave it on hold for the first time since the Global Financial Crisis in 2009.

Meanwhile, Commonwealth Bank said it strengthened its balance sheet during the first half, increasing its Basel III Common Equity Tier 1 (CET1) capital by 100 basis points to 10.2% on an APRA basis. This puts the group in the top quartile of banks globally for capital adequacy.

The Outlook

Although Australia's biggest banks have generated fantastic returns for investors over the years, they are still cyclical in nature. The economy is now facing a number of strong headwinds, exacerbated by the slowdown in mining, which could hinder the banks' ability to continue growing earnings in the near-term and thus impact the potential for shares to continue rising.

However, CBA's CEO, Ian Narev, said that the results showed the local economy had maintained its steady transition as it adjusts to slowing investment in the mining sector, while "sound monetary policy and a lower Australian dollar" were also providing a boost for the economy. He also noted that global volatility warrants caution, but that overreaction is also a threat.

Foolish takeaway

Commonwealth Bank's share price plummeted more than 4% on Tuesday, wiping billions of dollars from its market value. It is down 14.8% since the beginning of the year and 24% since peaking nearly 12 months ago.

Commonwealth Bank is a great business, and one I would happily add to my portfolio – but only for the right price and at the right time. At its current price, I think there are far better opportunities for investors to consider instead.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »